• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

FSM Clinical Devices With Pre-Loaded & Programmable Protocols: Range Updated

By: Press Release Distribution Service
April 30, 2026 at 19:37 PM EDT
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MEND Technology has expanded its frequency-specific microcurrent lineup with two new devices — one built for clinical beginners, one for advanced FSM practitioners with complex protocol needs.

Vancouver, United States, April 30, 2026 -- MEND Technology, a Washington State-based bio-resonance technology company, has announced updates to its frequency-specific microcurrent (FSM) device lineup. The expanded range introduces the MEND Wellness and the MEND Professional — two units developed to address distinct clinical workflow requirements and varying levels of FSM experience.

More details can be found at https://mendtechnology.com/

The two units serve distinct roles within the updated lineup. The MEND Wellness is designed for practitioners who are newer to FSM, shipping pre-loaded with a physical medicine protocol library so clinicians can begin treating patients right away. The MEND Professional, by contrast, is built for those who want deeper control over every aspect of their FSM sessions.

Growing demand for non-pharmaceutical pain management is shaping how practitioners think about clinical tools. According to a 2024 report from the National Center for Health Statistics, 24.3% of U.S. adults experienced chronic pain in 2023 — up from 20.5% in 2019 — representing an 18% rise in four years. That pattern points to growing demand for versatile, non-invasive treatment options across clinical settings, MEND Technology notes.

As more clinics adopt FSM, they do so at varying levels of experience — and the MEND Professional is built for practitioners seeking deeper control over their sessions. It supports manual, automated, and fully programmable modes, with capacity for up to 999 custom protocols, runtime adjustment of polarity, waveform, frequency, intensity, and session time, and the ability to daisy-chain up to nine protocols.

"Practitioners come to FSM from very different starting points," a MEND Technology spokesperson explains. "Whether someone is running their first pre-loaded session or building complex custom protocols, the goal is to have the right device for where they are — and for where they want to take their practice."

Headquartered in Washington State, MEND Technology describes itself as a solution-based company with a strong focus on innovative approaches for bio-resonance technologies. The company states that it remains actively committed to incorporating practitioner input and to keeping pace with the evolving landscape of energy medicine applications across diverse clinical practice settings.

Interested parties can find more information by visiting https://mendtechnology.com/

Contact Info:
Name: Sheila Flores
Email: Send Email
Organization: MEND Technology
Address: 6715 NE 63rd St Ste 103 PMB 120, Vancouver, Washington 98661, United States
Website: https://mendtechnology.com

Source: NewsNetwork

Release ID: 89190499

In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More
News headline image
Lilly's Double-Beat Widens the GLP-1 Gap—And a New Pill Could Make It Permanent ↗
Today 13:05 EDT
Via MarketBeat
Tickers LLY NVO
News headline image
SanDisk Earnings Crush Estimates With 251% Revenue Surge ↗
Today 12:30 EDT
Via MarketBeat
Tickers SNDK
News headline image
MaxLinear’s Explosive 200% Rally Looks Impressive—But Can It Last? ↗
Today 11:55 EDT
Via MarketBeat
Tickers AVGO MRVL MXL SOXX
News headline image
5 Reasons Rambus Stock Price Collapse Is One Hot Entry Point ↗
Today 11:20 EDT
Via MarketBeat
Tickers MU RMBS
News headline image
Viking Therapeutics Faces Timeline Risk—But Upside Could Be Huge ↗
Today 10:45 EDT
Via MarketBeat
Tickers LLY NVO VKTX

Recent Quotes

View More
Symbol Price Change (%)
AMZN  268.26
+3.20 (1.21%)
AAPL  280.14
+8.79 (3.24%)
AMD  360.54
+6.05 (1.71%)
BAC  53.24
-0.22 (-0.41%)
GOOG  383.22
+1.28 (0.34%)
META  608.75
-3.16 (-0.52%)
MSFT  414.44
+6.66 (1.63%)
NVDA  198.45
-1.12 (-0.56%)
ORCL  171.83
+10.44 (6.47%)
TSLA  390.82
+9.19 (2.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap